Mats Ahlberg

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Part of European Urology Open Science, p. 72-76, 2026

• DOI for Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Download full text (pdf) of Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 297-300, 2026

• DOI for Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Download full text (pdf) of Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 282-288, 2026

• DOI for Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Download full text (pdf) of Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Zaurito, Paolo; Gedeborg, Rolf; Garmo, Hans; Ventimiglia, Eugenio et al.

Part of Scandinavian journal of urology, p. 51-57, 2026

• DOI for Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study
• Download full text (pdf) of Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJU International, p. 629-638, 2026

• DOI for Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study
• Download full text (pdf) of Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Ventimiglia, Eugenio; Westerberg, Marcus; Wilberg Orrason, Andri; Ahlberg, Mats et al.

Part of European Urology Open Science, p. 72-76, 2026

• DOI for Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study
• Download full text (pdf) of Long-term Outcomes in Men with Stable PSA During 5-a Reductase Inhibitor Thera py After Negative Prostate Biopsy: Population-based Study

Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Ventimiglia, Eugenio; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 297-300, 2026

• DOI for Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality
• Download full text (pdf) of Extent of prostate cancer cases not registered in The National Cancer Register of Sweden and consequences for estimates of prostate cancer incidence and mortality

Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Galdieri, Armando; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Acta Oncologica, p. 282-288, 2026

• DOI for Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden
• Download full text (pdf) of Temporal trends in diagnostic work-up, treatment, and mortality in locally advanced prostate cancer in 2016-2024: nationwide, population-based study in Sweden

Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Zaurito, Paolo; Gedeborg, Rolf; Garmo, Hans; Ventimiglia, Eugenio et al.

Part of Scandinavian journal of urology, p. 51-57, 2026

• DOI for Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study
• Download full text (pdf) of Uptake of doublet and triplet therapy for men with de novo metastatic castration-sensitive prostate cancer. Population-based study

Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJU International, p. 629-638, 2026

• DOI for Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study
• Download full text (pdf) of Incidence and prognostic implications of PSA relapse after radical radiotherapy for prostate cancer: a population-based study

Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden

Hawez, Lewar; Bergengren, Oskar; Ahlberg, Mats; Garmo, Hans et al.

Part of Scandinavian journal of urology, p. 204-208, 2025

• DOI for Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden
• Download full text (pdf) of Suicide risk among urinary bladder cancer patients compared with the standard population: a nationwide study in Sweden

Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Zaurito, Paolo; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of Scandinavian journal of urology, p. 93-96, 2025

• DOI for Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study
• Download full text (pdf) of Prostate cancer incidence in Sweden before, during and after the COVID-19 pandemic. Population-based study

Potential gains from radical treatment of men with prostate cancer according to life expectancy

Irenaeus, Sandra; Garmo, Hans; Gedeborg, Rolf; Ahlberg, Mats et al.

Part of BJUI Compass, 2025

• DOI for Potential gains from radical treatment of men with prostate cancer according to life expectancy
• Download full text (pdf) of Potential gains from radical treatment of men with prostate cancer according to life expectancy

Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Ahlberg, Mats Steinholtz; Garmo, Hans; Stattin, Pär; Gedeborg, Rolf et al.

Part of Scandinavian journal of urology, p. 63-69, 2024

• DOI for Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study
• Download full text (pdf) of Triggers for transition from active surveillance to radical treatment of prostate cancer 2008-2020 – a case control study

Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study

Westerberg, Marcus; Ahlberg, Mats; Wilberg Orrason, Andri; Gedeborg, Rolf

Part of Scandinavian journal of urology, p. 207-209, 2024

• DOI for Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study
• Download full text (pdf) of Assessment of variability in life expectancy in older men by use of new comorbidity indices: A nationwide population-based study

Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Ahlberg, Mats Steinholtz; Garmo, Hans; Holmberg, Lars; Bill-Axelson, Anna

Part of European Urology Open Science, p. 166-173, 2023

• DOI for Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes
• Download full text (pdf) of Variations in the Uptake of Active Surveillance for Prostate Cancer and Its Impact on Outcomes

Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study

Ahlberg, Mats Steinholtz; Garmo, Hans; Adami, Hans-Olov; Andren, Ove et al.

Part of BMJ Open, 2022

• DOI for Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study
• Download full text (pdf) of Time without PSA recurrence after radical prostatectomy as a predictor of future biochemical recurrence, metastatic disease and prostate cancer death: a prospective Scandinavian cohort study

PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Ahlberg, Mats Steinholtz; Adami, Hans-Olov; Beckmann, Kerri; Bertilsson, Helena et al.

Part of BMJ Open, 2019

• DOI for PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design
• Download full text (pdf) of PCASTt/SPCG-17-a randomised trial of active surveillance in prostate cancer: rationale and design

Surveillance and follow-up of early prostate cancer

Ahlberg, Mats Steinholtz

2024

• Download full text (pdf) of Surveillance and follow-up of early prostate cancer